Table 3.
Author (Year) [Ref] |
Food/Intervention under Investigation | Type of Study | Participants | Assessment of Dietary Intake | Main Results |
---|---|---|---|---|---|
Wada K et al. (2013) [23] |
Soy and isoflavones | Prospective cohort study | 15,607 women | FFQ | A negative association between soy and isoflavone intake and breast cancer risk was observed solely in post-menopausal women. |
Li L et al. (2013) [46] |
Isoflavone | Case-control study | 1120 controls | FFQ | A protective effect of dietary isoflavone intake on breast cancer development was reported for both hospital outpatient and population controls. |
Ko KP et al. (2013) [55] |
Soy, vegetables, fruit, meat, and seafood | Case-control study | 2271 women | FFQ | Negative association between soy consumption and breast cancer risk in BRCA carriers |
Chen M et al. (2014) [51] |
Soy and isoflavone | Meta-analysis | 1,391,524 pre-menopausal and 579,33 post-menopausal women | n.d. | An inverse association was found between soy isoflavone intake and breast cancer incidence, independently of menopausal status, solely in Asian women. |
Woo HD et al. (2014) [52] |
Soy products, fruits, and vegetables | Meta-analysis | 8112 participants | n.d. | Different kinds of soy foods were inversely associated with breast cancer risk in both pre-menopausal and post-menopausal women. |
Wu J et al. (2016) [45] |
Meat, soy, milk, yogurt, poultry, fish, eggs, and nuts | Meta-analysis | 452,916 participants | n.d. | Reduced breast cancer risk with high soy consumption. |
Zhao TT et al. (2017) [48] |
Soy and isoflavone | Meta-analysis | 648,913 participants | FFQs, self-administered questionnaires, and mail survey questionnaires | A statistically significant inverse association was shown between high versus low soy consumption and breast cancer risk. |
Tan MM et al. (2018) [42] |
Soy, breastfeeding, and PA | Case-control study | 7663 women | Interviews and FFQs | High soy milk and soy product consumption demonstrated an inverse association with breast cancer incidence. |
Wei Y et al. (2020) [43] |
Soy and isoflavones | Prospective cohort study and meta-analysis | 30,0852 women for the cohort study and 513,313 participants for the meta-analysis | FFQs, physical measurements, resurveys, 24-h dietary recalls | The cohort study revealed no association between moderate or high soy consumption and breast cancer. The meta-analysis showed a 3% reduced risk of breast cancer development with each 10 mg/day increase in isoflavone intake. |
Wang Q et al. (2020) [49] |
Tofu | Meta-analysis | 109,813 participants | n.d. | A protective effect of tofu consumption on breast cancer development was observed independent of menopausal status. |
Okekunle AP et al. (2020) [53] |
Soy and isoflavone | Meta-analysis | 29,810 participants | n.d. | Increased soy consumption reduced breast cancer risk, especially in pre-menopausal women and for ER-negative subtype development. |
Lu LW et al. (2022) [24] |
Isoflavones versus placebo | Clinical trial | 194 pre-menopausal women | N.A. | The authors found a decrease in breast tissue density with higher isoflavone intake, especially in pre-menopausal women. |
Boutas I et al. (2022) [44] |
Soy and isoflavones | Meta-analysis | 485,495 participants | FFQ | High soy consumption reduced the breast cancer risk in pre- and post-menopausal women. |
Cao S et al. (2022) [54] |
Vegetable-fruit-soy dietary pattern | Case-control study | 1753 women | FFQ | Higher soy consumption reduced breast cancer development in post-menopausal women, especially ER- and ER-/PgR-negative subtypes. |
Shin S et al. (2023) [47] |
Fruits, vegetables, meat, soy, green tea, alcohol | Meta-analysis | 216,216 participants | n.d. | A protective effect of soy protein and isoflavone intake on breast cancer incidence was observed, but no correlation was found with soy food consumption. |
Rajaram N et al. (2023) [50] |
Soy isoflavone supplement versus isoflavones from dietary sources | Clinical trial | 90 women | FFQ | Moderate and high intake of soy reduced mammographic density in both pre-menopausal and recently menopausal women. |